TY - JOUR
T1 - Guidance for the Primary Care Provider in Identifying Infants With Biliary Atresia by 2–4 Weeks of Life
T2 - Clinical Report
AU - SECTION ON GASTROENTEROLOGY, HEPATOLOGY, AND NUTRITION
AU - COMMITTEE ON FETUS AND NEWBORN
AU - SECTION ON SURGERY
AU - Harpavat, Sanjiv
AU - Aucott, Susan W.
AU - Karpen, Saul J.
AU - Shneider, Benjamin L.
AU - Wang, Kasper
AU - Cohen, Mitchell B.
AU - Brumbaugh, David
AU - Dotson, Jennifer L.
AU - Lightdale, Jenifer R.
AU - Mallon, Daniel
AU - Oliva-Hemker, Maria M.
AU - Burrowes, Debra L.
AU - Eichenwald, Eric C.
AU - Guillory, Charletta
AU - Hand, Ivan Leslie
AU - Hudak, Mark L.
AU - Kaufman, David Alan
AU - Martin, Camilia Rivera
AU - Parker, Margaret Graham Kemper
AU - Pramanik, Arun Kumar
AU - Wade, Kelly Cant
AU - Couto, Jim
AU - Davidoff, Andrew
AU - Beierle, Elizabeth
AU - Besner, Gail E.
AU - Browne, Marybeth
AU - Downard, Cynthia D.
AU - Gow, Kenneth
AU - Islam, Saleem
AU - Walsh, Danielle
AU - Thorne, Vivian
AU - Jung, Christina
AU - Lehmann, Christoph U.
AU - Okechukwu, Kymika
N1 - Publisher Copyright:
Copyright © 2025 by the American Academy of Pediatrics.
PY - 2025/3
Y1 - 2025/3
N2 - This report helps pediatric primary care providers quickly identify infants with biliary atresia, which has the potential to improve outcomes and reduce need for liver transplant. The strategy is intended to be used between 2 and 4 weeks of life at the “By 1 month” well-child visit in the Bright Futures/American Academy of Pediatrics “Recommendations for Preventive Pediatric Health Care.” The strategy involves examining every infant’s eye color, stool color, and prior laboratory results to determine whether measurement of a direct or conjugated bilirubin level is warranted.
AB - This report helps pediatric primary care providers quickly identify infants with biliary atresia, which has the potential to improve outcomes and reduce need for liver transplant. The strategy is intended to be used between 2 and 4 weeks of life at the “By 1 month” well-child visit in the Bright Futures/American Academy of Pediatrics “Recommendations for Preventive Pediatric Health Care.” The strategy involves examining every infant’s eye color, stool color, and prior laboratory results to determine whether measurement of a direct or conjugated bilirubin level is warranted.
UR - http://www.scopus.com/inward/record.url?scp=86000348163&partnerID=8YFLogxK
U2 - 10.1542/peds.2024-070077
DO - 10.1542/peds.2024-070077
M3 - Article
C2 - 39961332
AN - SCOPUS:86000348163
SN - 0031-4005
VL - 155
JO - Pediatrics
JF - Pediatrics
IS - 3
M1 - e2024070077
ER -